Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» With private equity bidders lined up, Sanofi's EU generics could go for up to $2.4B: Reuters
With private equity bidders lined up, Sanofi's EU generics could go for up to $2.4B: Reuters
With private equity bidders lined up, Sanofi's EU generics could go for up to $2.4B: Reuters
Submitted by
admin
on February 6, 2018 - 8:50pm
Source:
Fierce Pharma
News Tags:
M&A
Sanofi
Europe
generics
Headline:
With private equity bidders lined up, Sanofi's EU generics could go for up to $2.4B: Reuters
Do Not Allow Advertisers to Use My Personal information
